These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
850 related articles for article (PubMed ID: 18329858)
61. In vitro activity of verapamil alone and in combination with fluconazole or tunicamycin against Candida albicans biofilms. Yu Q; Ding X; Xu N; Cheng X; Qian K; Zhang B; Xing L; Li M Int J Antimicrob Agents; 2013 Feb; 41(2):179-82. PubMed ID: 23265915 [TBL] [Abstract][Full Text] [Related]
62. Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms. Cataldi V; Di Campli E; Fazii P; Traini T; Cellini L; Di Giulio M Med Mycol; 2017 Aug; 55(6):624-634. PubMed ID: 27915303 [TBL] [Abstract][Full Text] [Related]
63. Silver colloidal nanoparticles: antifungal effect against adhered cells and biofilms of Candida albicans and Candida glabrata. Monteiro DR; Gorup LF; Silva S; Negri M; de Camargo ER; Oliveira R; Barbosa DB; Henriques M Biofouling; 2011 Aug; 27(7):711-9. PubMed ID: 21756192 [TBL] [Abstract][Full Text] [Related]
64. Commercial mouthwashes are more effective than azole antifungals against Candida albicans biofilms in vitro. Ramage G; Jose A; Coco B; Rajendran R; Rautemaa R; Murray C; Lappin DF; Bagg J Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Apr; 111(4):456-60. PubMed ID: 21310633 [TBL] [Abstract][Full Text] [Related]
65. Cyclosporine A decreases the fluconazole minimum inhibitory concentration of Candida albicans clinical isolates but not biofilm formation and cell growth. Wibawa T; Nurrokhman ; Baly I; Daeli PR; Kartasasmita G; Wijayanti N Trop Biomed; 2015 Mar; 32(1):176-82. PubMed ID: 25801268 [TBL] [Abstract][Full Text] [Related]
66. Eugenol and thymol, alone or in combination, induce morphological alterations in the envelope of Candida albicans. Braga PC; Sasso MD; Culici M; Alfieri M Fitoterapia; 2007 Sep; 78(6):396-400. PubMed ID: 17590533 [TBL] [Abstract][Full Text] [Related]
67. In vitro activity of baicalein against Candida albicans biofilms. Cao Y; Dai B; Wang Y; Huang S; Xu Y; Cao Y; Gao P; Zhu Z; Jiang Y Int J Antimicrob Agents; 2008 Jul; 32(1):73-7. PubMed ID: 18374543 [TBL] [Abstract][Full Text] [Related]
68. Candida albicans biofilm formation on peptide functionalized polydimethylsiloxane. De Prijck K; De Smet N; Rymarczyk-Machal M; Van Driessche G; Devreese B; Coenye T; Schacht E; Nelis HJ Biofouling; 2010; 26(3):269-75. PubMed ID: 20054722 [TBL] [Abstract][Full Text] [Related]
69. Effect of ferrocene-substituted porphyrin RL-91 on Candida albicans biofilm formation. Lippert R; Vojnovic S; Mitrovic A; Jux N; Ivanović-Burmazović I; Vasiljevic B; Stankovic N Bioorg Med Chem Lett; 2014 Aug; 24(15):3506-11. PubMed ID: 24929472 [TBL] [Abstract][Full Text] [Related]
70. Amphotericin B lipid complex is efficacious in the treatment of Candida albicans biofilms using a model of catheter-associated Candida biofilms. Mukherjee PK; Long L; Kim HG; Ghannoum MA Int J Antimicrob Agents; 2009 Feb; 33(2):149-53. PubMed ID: 18945596 [TBL] [Abstract][Full Text] [Related]
71. Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth. Haque F; Alfatah M; Ganesan K; Bhattacharyya MS Sci Rep; 2016 Mar; 6():23575. PubMed ID: 27030404 [TBL] [Abstract][Full Text] [Related]
72. In vitro analyses of the effects of heparin and parabens on Candida albicans biofilms and planktonic cells. Miceli MH; Bernardo SM; Ku TS; Walraven C; Lee SA Antimicrob Agents Chemother; 2012 Jan; 56(1):148-53. PubMed ID: 21986822 [TBL] [Abstract][Full Text] [Related]
73. The Activity of Fungichromin against the Formation of Candida albicans Biofilm. An D; Wang X; Li J; Jiang S; Ma X; Zhang H; Shi H; Sun H; Ye L; Li J Biol Pharm Bull; 2016 Dec; 39(12):1948-1954. PubMed ID: 27615430 [TBL] [Abstract][Full Text] [Related]
74. Effect of oral bacteria on growth and survival of Candida albicans biofilms. Thein ZM; Samaranayake YH; Samaranayake LP Arch Oral Biol; 2006 Aug; 51(8):672-80. PubMed ID: 16620775 [TBL] [Abstract][Full Text] [Related]
75. Penetration of antifungal agents through Candida biofilms. Douglas LJ Methods Mol Biol; 2009; 499():37-44. PubMed ID: 19152037 [TBL] [Abstract][Full Text] [Related]
77. Environmental pH influences Candida albicans biofilms regarding its structure, virulence and susceptibility to fluconazole. de Vasconcellos AA; Gonçalves LM; Del Bel Cury AA; da Silva WJ Microb Pathog; 2014; 69-70():39-44. PubMed ID: 24685701 [TBL] [Abstract][Full Text] [Related]
78. Interactions of Candida albicans with other Candida spp. and bacteria in the biofilms. El-Azizi MA; Starks SE; Khardori N J Appl Microbiol; 2004; 96(5):1067-73. PubMed ID: 15078523 [TBL] [Abstract][Full Text] [Related]
79. [Architecture, influencing factors, and sensitivity to antifungal agents of Candida biofilm]. Sun QN; Fang K Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):385-8. PubMed ID: 12905659 [TBL] [Abstract][Full Text] [Related]
80. Chlorhexidine-impregnated PEM/THFM polymer exhibits superior activity to fluconazole-impregnated polymer against Candida albicans biofilm formation. Salim N; Silikas N; Satterthwaite JD; Moore C; Ramage G; Rautemaa R Int J Antimicrob Agents; 2013 Feb; 41(2):193-6. PubMed ID: 23127479 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]